Tag index

#Drug-Pricing

Events indexed under #Drug-Pricing — 11 entries in the record.

11 events From Jan 1, 2002 To Jan 15, 2026 Open in filter view →

Activity over time Events per year

Date	Event	Lanes	Status
2026-01-15	Trump Unveils 'Great Healthcare Plan' - One-Page Framework with No Specifics, Fails to Address ACA Premium Crisis Donald Trump · Mehmet Oz · CMS		confirmed
2025-11-06	Trump Announces Weight Loss Drug Price Deals With Eli Lilly and Novo Nordisk Donald Trump · Eli Lilly · Novo Nordisk · U.S. Department of Health and Human Services		reported
2024-09-20	FTC Sues Big Three PBMs for Artificially Inflating Insulin Prices Through Rebate Schemes Federal Trade Commission · Lina Khan · CVS Caremark · Express Scripts · +4		confirmed
2023-05-10	Senate Hearing Exposes PBM Insulin Profiteering: 75% of Sales Go to Rebates and Fees Bernie Sanders · Senate HELP Committee · Lars Fruergaard Jorgensen · Paul Hudson · +7		confirmed
2023-01-01	Cancer Drug Shortage Crisis Enables Gray Market Profiteering - Carboplatin Price Jumps from $50 to $500 Per Vial Big Pharma · Teva Pharmaceuticals · Food and Drug Administration · Gray Market Vendors · +1		confirmed
2018-10-16	AbbVie Humira Patent Thicket Delays US Biosimilars Until 2023 Despite 2016 Patent Expiration and European Competition AbbVie · Amgen · Samsung Bioepis · Mylan · +4		confirmed
2015-11-19	Johns Hopkins Study Exposes Orphan Drug Act Gaming - Seven of Top 10 Drugs Exploiting Tax Breaks for Rare Diseases Johns Hopkins University · Food and Drug Administration · AbbVie · Roche · +5		confirmed
2015-10-31	Valeant Pharmaceuticals Scandal Exposes Systematic Price Gouging Strategy - 3000% Increase on Syprine, Philidor Fraud Network Valeant Pharmaceuticals · J. Michael Pearson · Philidor Rx Services · William Ackman · +3		confirmed
2013-06-17	Supreme Court Allows Antitrust Challenge to Pay-for-Delay Drug Settlements Costing Consumers $3.5 Billion Annually Supreme Court of the United States · Federal Trade Commission · Solvay Pharmaceuticals · Actavis · +2		confirmed
2007-08-27	Questcor Raises Acthar Gel Price from $1,600 to $23,000 Overnight - Eventually Reaching 97,000% Increase Through Bribery Scheme Questcor Pharmaceuticals · Mallinckrodt · Federal Trade Commission · Humana · +2		confirmed
2002-01-01	Insulin Prices Begin Tripling 2002-2013 as Three Manufacturers Control 99% of Market - From $231 to $762 Annually Eli Lilly · Novo Nordisk · Sanofi · Congressional Diabetes Caucus · +1		confirmed